← Leaderboards
Hu Yang
Virginia Commonwealth University
$3,062,178
Attributed
$5,729,190
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $634.5K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,729,190 · 4
By mechanism
R01$5,334,024 · 3
R21$395,166 · 1
Top collaborators
- Xiaorong Liu4 shared
- Shobha Ghosh3 shared
- Uday B Kompella3 shared
- Siddhartha S Ghosh1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Shobha Ghosh$5,579,810
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoNanoparticleDendrimersDrug Delivery SystemsPharmaceutical PreparationsHydrogelsKineticsDrug FormulationsUptakeMediatingBlindnessGlaucomaBiological AvailabilityPhysiologic Intraocular PressureDoseCompliance BehaviorTissuesCharacteristicsAdverse EffectsCellsPathway InteractionsGenerationsExcisionDosage
Grant awards (13)
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma$314,983
R01 · FY2025 · EY · contact PI
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma$184,205
R01 · FY2025 · EY · contact PI
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma$499,189
R01 · FY2024 · EY · contact PI
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma$513,314
R01 · FY2023 · EY · contact PI
Modulating Macrophage Function in Atherosclerosis by Functionalized Nanoparticles$634,543
R01 · FY2021 · HL · contact PI
Modulating macrophage function in atherosclerosis by functionalized nanoparticles$634,543
R01 · FY2020 · HL
Modulating macrophage function in atherosclerosis by functionalized nanoparticles$634,543
R01 · FY2019 · HL
Modulating macrophage function in atherosclerosis by functionalized nanoparticles$633,543
R01 · FY2018 · HL
Hybrid Nanoparticles for Glaucoma$422,454
R01 · FY2016 · EY · contact PI
Hybrid Nanoparticles for Glaucoma$414,003
R01 · FY2015 · EY · contact PI
Hybrid Nanoparticles for Glaucoma$448,704
R01 · FY2014 · EY · contact PI
Brain-targeted nanomedicine via buccal administration$138,864
R21 · FY2010 · NS · contact PI
Brain-targeted nanomedicine via buccal administration$256,302
R21 · FY2009 · NS · contact PI